A novel normalisation technique for voxel size dependent radiomic features in oesophageal cancer [Abstract] by Whybra, P. et al.
S522                                                                                                                                                         ESTRO 38 
 
 
 
partial responders eventually advance in to complete 
responders (approximately 70%). To support decision-
making in additional diagnostic and therapeutic 
interventions, it is crucial to identify those who develop a 
complete response from those who have residue or 
recurrence, i.e. persistent disease. Therefore, this study 
aims to identify ∆image biomarkers from MRI scans 2 
months after radiotherapy that may identify patients that 
will advance into persistent disease, and for which a more 
aggressive approach may be needed. 
Material and Methods 
This is a retrospective analysis in a prospective cohort of 
consecutive HNC patients treated between 10-2012 and 
11-2014 at our department. Included were those who had 
a partial tumour response 2 months after treatment, and 
in whom pre- and post T1-TSE contrast enhanced MRI 
(T1ce-MRI) scan was acquired. These MRI scans were 
standardized to fat tissue. Subsequently, image 
biomarkers, representing geometric, intensity and 
textural characteristics of the primary tumour were 
extracted from the standardized pre- and post T1ce-MRI 
scans. Univariable logistic regression was performed to 
identify significant ∆image biomarkers, where the Area 
Under the ROC Curve (AUC) gives an indication of the 
discriminative power. Pearson correlation (<0.80) was 
used to select independent variables.  Unpaired t-test was 
performed to test a significant difference between the 
∆image biomarkers in patients with and without persistent 
disease. 
Results 
Out of the 51 partial responders, 12 (24%) patients 
progressed into persistent disease, including 8 residues 
and 4 recurrences. The median follow-up time was 44 
months (range: 4-63 months). Univariable analysis showed 
that 26 of the in total 84 ∆image biomarkers were 
significantly associated with persistent disease. After the 
correlation analysis, 6 independent significant variables 
were identified (Table 1). The t-test showed that 5 of 6 
∆image biomarkers were significantly different in the 
patient with and without persistent disease (Table 1). The 
best performing ∆image biomarker, the information 
correlation 1 (texture feature) suggests that tumours that 
show a large reduction in heterogeneity are more likely to 
result in persistent disease than tumours that have 
increased heterogeneity (examples are shown in Figure 1). 
Conclusion 
The results of this pilot study suggest that pre- and post- 
MRI information have potential to identify patients with 
radiological partial response at 2 months after 
radiotherapy will advance into complete responders or 
progress into persistent disease.  This information may 
support clinical decision-making in cases with partial 
response at response evaluation using MRI. 
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Purpose or Objective 
Modern radiotherapy (RT) protocols for prostate cancer 
allow dose escalation to the prostate, however, the risk of 
late genitourinary (GU) toxicity is still dose-limiting. The 
associations between GU toxicity and dose/volume 
parameters in the bladder remain not fully understood. 
The weak associations may be due to considerable changes 
occurring in bladder volume, shape and position during the 
RT course. By using well-established methods for shape 
analysis and algorithms from machine learning for 
dimensionality reduction and clustering, we evaluated 
whether parameterized shape descriptors of the bladder 
from the first week of treatment better classify patients 
into exhibiting and not exhibiting late GU toxicity. 
Material and Methods 
A matched case-control study was performed within a 
cohort of 258 prostate cancer patients, where a previous 
analysis had not shown any differences in planned or 
actually delivered dose/volume endpoints between cases 
and controls. Patients were treated to prescription doses 
of 77.4–81.0 Gy using daily cone-beam CT (CBCT)-
guidance. Twenty-seven patients (10.5%) presented late 
RTOG GU ≥ Grade 2 toxicity and those without symptoms 
prior to treatment (N=8) were selected as cases. Each case 
was matched with three controls based on pre-treatment 
GU symptoms, age, Gleason score, follow-up time, and 
hormone therapy. CBCTs from the first week of treatment 
were rigidly registered to the planning CT using the 
recorded treatment shifts, and the bladder was manually 
contoured on each CBCT. Each bladder volume was 
described using seventeen shape descriptors. In order to 
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detect similarities across patients we performed 
dimensionality reduction using the t-distributed stochastic 
neighborhood embedding (t-SNE) followed by a Gaussian 
Mean Shift Clustering. ANOVA tests for each descriptor and 
each cluster were performed to find statistically 
significant differences. A repeated measurements model 
was fitted at each cluster to evaluate within-cluster 
trends for patients with and without toxicity (Fig. 1). 
 
 
 
Results 
Two clusters with distinct shape characteristics comprised 
85% of the patients while a third cluster (15%) included 
outliers. Clusters remained similar when data from the 
entire RT course was pooled in the t-SNE classification. 
Significant differences between cases and controls were 
observed at each cluster in seven descriptors (convexity 
and elliptic variance along the three principal axes, and 
compactness). In cluster 1 (small bladder volumes) more 
convex and round bladders shapes were associated with 
higher toxicity risk, while in cluster 2 (large bladder 
volumes) more concave and elliptical shapes were 
associated with higher risk of toxicity (Fig. 2).  
 
 
 
Conclusion 
Bladder shape changes occurring during the first week of 
treatment show potential to predict the risk of developing 
late GU toxicity after RT for prostate cancer. Patient-
specific changes in bladder shape might be related to the 
exposure of the most radiosensitive areas of the bladder 
to high doses. 
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Purpose or Objective 
In oncology, radiomic studies hope to identify quantitative 
imaging features that predict survival and therapy 
response. To be clinically useful, features need to be 
robust. For 3D features that measure tumour 
heterogeneity, isotropic voxels are advised to ensure no 
directional bias [1]. Normally, PET/CT scans are not 
isotropic and require interpolation. The voxel size chosen 
is important; resampling a scan to smaller dimensions 
increases the number of voxels in a region of interest 
(ROI). An intrinsic dependency between common features 
and number of voxels in a ROI has been found [2]. This 
study evaluates methods to improve feature robustness 
and introduces a novel normalisation technique for voxel 
size dependent radiomic features in oesophageal cancer 
(OC). 
Material and Methods 
18F-FDG PET images (scanned and segmented with the 
same protocol) from 441 OC patients (training=353, 
validation=88) were included [3]. Standardised and 
validated [1] in-house feature extraction algorithms were 
used. Voxel intensities were discretised with a fixed bin 
width (0.5 SUV). Five selected features recommended for 
voxel normalisation [2] were extracted from the original 
scan dimension and 5 isotropic sizes. Patients were ranked 
based on the feature result of the original dimension. 
Surface models were generated on the training dataset to 
normalise each feature using the voxel size and feature 
value. A concordance correlation coefficient (CCC) was 
used to determine reproducibility between features 
extracted from the original dimension and a range of 
interpolated voxel sizes.  
Results 
Fig.1 shows development of a surface model and results 
for a selected feature, run length non-uniformity (RLNU). 
Fig.2 is a feature heatmap of the CCC results for each 
voxel dimension for the validation dataset. There are 3 
versions of each feature; standard (CCC 0.16-0.96), voxel 
number normalised (CCC 0.08-0.99), and surface model 
normalised (CCC 0.95-0.99). Features normalised with a 
surface model performed the best in each case. 
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Fig.1: Results for RLNU (training). TOP: (left) feature 
calculated at each voxel dimension against patient rank. 
(right) Feature normalised by voxel number in 
ROI. BOTTOM: (left) Surface model to calculate feature 
change. (right) Surface model shifted result. 
 
 
 
Fig.2: CCC heatmap for each feature (validation dataset) 
Conclusion 
We developed, tested and validated a novel normalisation 
technique for voxel size dependent radiomic features. On-
going work aims at validating the proposed approach on 
other imaging modalities.  
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Purpose or Objective 
Radiomics aims at extracting quantitative features from 
medical images. Several studies focussed on the potential 
value of radiomic analysis in predicting tumour response 
for oesophageal cancer (OC) patients using contrast 
enhanced CT images. However, in clinical practice 
contrast agents are not always administrable, making the 
development of a new radiomic model necessary. In this 
work, we investigated the usefulness of radiomic features 
extracted from contrast and non-contrast enhanced CT 
scans in the development of a prognostic model in OC. 
Material and Methods 
CT images and radiotherapy volumes of 213 patients from 
a clinical trial in OC1were processed with the CERR 
package2. Patients were divided into 3 groups: mixed 
group (MG) with contrast and non-contrast enhanced CT 
images (n=213), contrast group (CG) with contrast 
enhanced CT scans (n=138) and non-contrast group (nCG) 
with non-contrast enhanced CT data (n=75). Radiomic 
features were automatically extracted in 2D and 3D in 
compliance with the IBSI3, using in-house developed data 
analytics software4. Stable features were selected as the 
ones with similar intra-groups distributions (Kruskal-Wallis 
test). Corresponding 2D and 3D stable features within each 
group were evaluated for differences (Wilcoxon signed 
rank test). Remaining filtered features and clinical 
characteristics were used to develop a prognostic model 
with the Cox regression method. 
Results 
A total of 119 2D and 3D features were computed from 
each group. The Kruskal-Wallis test excluded 82, 3 and 6 
unstable features obtained from MG, from CG and from 
nCG, respectively (Fig. 1). Some stable features (6 for MG, 
15 for CG and 17 for nCG) did not show a significant 
difference if extracted considering 1 tumour layer at a 
time or considering the whole tumour volume. Among 
stable features, 4 features showed no difference if 
obtained from 3D or 2D data and were stable in all the 3 
groups. The Cox regression model, constructed with 8 
clinical and radiomic variables, identified 1 feature 
(GLDZM zone distance variance) associated with survival 
(Table 1). 
 
 
 
Conclusion 
The prognostic model has identified 1 texture significantly 
and independently correlated with overall survival. This 
